An 87-year-old woman with hypertension and hyperlipidemia complained of dyspnea and a fever. Computed tomography (CT) revealed a left-sided pleural effusion, revealing a lymphocytic exudate with 74.3 IU/L of adenosine deaminase, and spondylodiscitis in the Th6 segment ([Picture A, B](#g001){ref-type="fig"}). Sputum culture revealed *Mycobacterium tuberculosis* without drug resistance. We started antituberculosis therapy with isoniazid (200 mg/day), rifampin (450 mg/day), and ethambutol (750 mg/day) with good adherence. Her fever recurred two weeks following antituberculosis therapy initiation. One month later, CT revealed a new mass in the right upper lobe that was positive on tuberculosis-polymerase chain reaction (assessed using CT-guided biopsy) and progressive spondylodiscitis ([Picture C, D](#g001){ref-type="fig"}). Five months later, CT showed that the mass in the right upper lobe had shrunk in size with progressive spondylodiscitis ([Picture E, F](#g001){ref-type="fig"}). We diagnosed this clinical course as tuberculosis-immune reconstitution inflammatory syndrome (IRIS). Tuberculosis-IRIS is not a rare phenomenon; however, it can be misdiagnosed as superimposed infections, treatment failure, or tuberculosis relapse ([@B1]).
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